Penserra Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1K Hold
12
﹤0.01% 1102
2026
Q1
$1K Sell
12
-6,913
-100% -$634K ﹤0.01% 1076
2025
Q4
$622K Buy
6,925
+6,907
+38,372% +$655K 0.01% 521
2025
Q3
$1K Sell
18
-4,715
-100% -$467K ﹤0.01% 1016
2025
Q2
$431K Buy
4,733
+1,350
+40% +$131K 0.01% 541
2025
Q1
$382K Sell
3,383
-1,292
-28% -$138K 0.01% 637
2024
Q4
$492K Buy
4,675
+4,657
+25,872% +$500K 0.01% 571
2024
Q3
$1K Hold
18
﹤0.01% 1094
2024
Q2
$2K Hold
18
﹤0.01% 1197
2024
Q1
$2K Sell
18
-951
-98% -$119K ﹤0.01% 1168
2023
Q4
$117K Sell
969
-202
-17% -$22.5K ﹤0.01% 877
2023
Q3
$131K Sell
1,171
-1,686
-59% -$214K ﹤0.01% 840
2023
Q2
$415K Buy
2,857
+2,845
+23,708% +$387K 0.01% 595
2023
Q1
$1K Hold
12
﹤0.01% 1090
2022
Q4
$1K Buy
+12
New +$1.39K ﹤0.01% 1127
2018
Q4
Sell
-3,222
Closed -$411K 801
2018
Q3
$411K Buy
3,222
+455
+16% +$54.1K 0.03% 331
2018
Q2
$299K Buy
2,767
+575
+26% +$62.6K 0.02% 282
2018
Q1
$232K Buy
2,192
+173
+9% +$20.1K 0.02% 244
2017
Q4
$236K Buy
2,019
+317
+19% +$35.8K 0.03% 214
2017
Q3
$194K Buy
1,702
+202
+13% +$23.3K 0.05% 205
2017
Q2
$186K Buy
1,500
+173
+13% +$20.5K 0.07% 221
2017
Q1
$157K Buy
1,327
+116
+10% +$13.1K 0.02% 251
2016
Q4
$121K Sell
1,211
-1,255
-51% -$135K 0.01% 311
2016
Q3
$310K Buy
2,466
+1,965
+392% +$243K 0.04% 124
2016
Q2
$59K Buy
501
+167
+50% +$18.9K 0.01% 303
2016
Q1
$34 Buy
334
+112
+50% +$10.8K ﹤0.01% 357
2015
Q4
$22K Buy
+222
New +$21.7K ﹤0.01% 405

Other funds holding ZBH

Penserra Capital Management's ZBH Position: Q2 2026 in Review

Penserra Capital Management held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 12 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

Penserra Capital Management first reported a position in ZBH in Q4 2015 and has held it in 27 quarters since. The position peaked at $622K in Q4 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Penserra Capital Management held 12 shares of Zimmer Biomet worth $1K as of Q2 2026.
  • Penserra Capital Management left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #1102 holding.
  • Penserra Capital Management first reported a position in Zimmer Biomet in Q4 2015 and has held it in 27 quarters since.
  • Penserra Capital Management's Zimmer Biomet position peaked at $622K in Q4 2025.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.